Earnings summaries and quarterly performance for Kimball Electronics.
Executive leadership at Kimball Electronics.
Ric Phillips
Detailed
Chief Executive Officer
CEO
AB
Adam Baumann
Detailed
Chief Accounting Officer
DH
Doug Hass
Detailed
Chief Legal & Administrative Officer, Secretary
JC
Jana Croom
Detailed
Chief Financial Officer
JD
Jessica DeLorenzo
Detailed
Chief Human Resources Officer
KT
Kathy Thomson
Detailed
Chief Commercial Officer
SK
Steven Korn
Detailed
Chief Operating Officer
Board of directors at Kimball Electronics.
Research analysts who have asked questions during Kimball Electronics earnings calls.
AS
Anja Soderstrom
Sidoti & Company, LLC
6 questions for KE
Also covers: ATEN, BHE, DAKT +11 more
Derek Soderberg
Cantor Fitzgerald
5 questions for KE
Also covers: AMPX, ARRY, ECX +8 more
Jaeson Schmidt
Lake Street Capital Markets
4 questions for KE
Also covers: AVNW, BHE, BKSY +13 more
MC
Michael Crawford
B. Riley Securities, Inc.
3 questions for KE
Also covers: ASTS, ATEX, CMTL +9 more
MC
Mike Crawford
B. Riley Securities
3 questions for KE
Also covers: ASTS, ATEX, CMTL +8 more
HS
Hendi Susanto
Gabelli Funds
2 questions for KE
Also covers: ATEN, BELFA, CTS +1 more
MM
Max Michaelis
Lake Street Capital
2 questions for KE
Also covers: BHE, DHX, QUBT +1 more
Recent press releases and 8-K filings for KE.
Kimball Electronics Reports Q2 2026 Results and Raises Fiscal 2026 Guidance
KE
Earnings
Guidance Update
New Projects/Investments
- Kimball Electronics reported Q2 fiscal 2026 net sales of $341 million, a 5% year-over-year decrease, with medical sales growing 15% to $96 million and automotive sales declining 13% to $162 million.
- The company raised its fiscal 2026 guidance, now expecting net sales between $1.4 billion and $1.46 billion (up from $1.35 billion to $1.45 billion) and adjusted operating income of 4.2% to 4.5% of net sales (up from 4.0% to 4.25%).
- Adjusted operating income for Q2 was $15.3 million, or 4.5% of net sales, an improvement from 3.7% in the prior year, driven by favorable mix, facility closure, and FX rates.
- Cash generated from operations was $6.9 million, marking the eighth consecutive quarter of positive cash flow, and $4.3 million was used to repurchase 149,000 shares.
- The company announced a rebranding to Kimball Solutions starting July 2026, reflecting an expanded portfolio, and highlighted the grand opening of its new medical manufacturing facility in Indianapolis.
1 day ago
Kimball Electronics Reports Q2 2026 Results and Raises Fiscal 2026 Guidance
KE
Earnings
Guidance Update
New Projects/Investments
- Kimball Electronics reported Q2 fiscal 2026 net sales of $341.3 million, a 5% decrease year-over-year, and adjusted net income of $6.9 million, or $0.28 per diluted share.
- The company raised its fiscal 2026 net sales guidance to $1.4-$1.46 billion and adjusted operating income guidance to 4.2%-4.5% of net sales, driven by strength in the medical vertical and ramp-up of automotive programs.
- In Q2 fiscal 2026, the medical vertical achieved 15% year-over-year sales growth to $96 million, while automotive sales declined 13% to $162 million and industrial sales decreased 5% to $83 million.
- Strategic developments include the upcoming rebranding to Kimball Solutions starting July 2026 and the grand opening of a new 300,000 sq ft medical manufacturing facility in Indianapolis.
1 day ago
Kimball Electronics Reports Q2 2026 Results and Raises FY2026 Guidance
KE
Earnings
Guidance Update
New Projects/Investments
- Kimball Electronics reported Q2 fiscal 2026 net sales of $341 million, a 5% year-over-year decrease, while the medical vertical grew 15% to $96 million. The gross margin rate improved to 8.2% (up 160 basis points), and adjusted operating income reached $15.3 million, or 4.5% of net sales.
- The company raised its fiscal 2026 guidance, now expecting net sales between $1.4 billion and $1.46 billion and adjusted operating income between 4.2% and 4.5% of net sales.
- Strategic initiatives include rebranding as Kimball Solutions and the grand opening of a new 300,000 sq ft medical manufacturing facility in Indianapolis, which is expected to be a near-term drag on margins but accretive long-term.
- Kimball Electronics generated $6.9 million in cash from operating activities, marking the eighth consecutive quarter of positive cash flow, and repurchased 149,000 shares for $4.3 million in Q2.
1 day ago
Kimball Electronics Reports Q2 Results and Raises Fiscal 2026 Guidance
KE
Earnings
Guidance Update
Share Buyback
- Kimball Electronics reported Q2 fiscal 2026 revenue of $341.3 million, a 5% decrease compared to Q2 fiscal 2025, with diluted EPS of $0.15 and adjusted diluted EPS of $0.28.
- The company experienced strong sales growth in the medical vertical, increasing 15% year-over-year.
- Kimball Electronics raised its guidance for fiscal year 2026, now expecting net sales in the range of $1,400 - $1,460 million and adjusted operating income of 4.2% - 4.5% of net sales.
- The company generated $6.9 million in cash from operations and repurchased 149,000 shares of common stock for $4.3 million during the quarter.
2 days ago
Kimball Electronics Outlines Strategic Focus on Medical Business and Growth Initiatives
KE
New Projects/Investments
M&A
Revenue Acceleration/Inflection
- Kimball Electronics is undergoing a significant strategic shift, prioritizing its medical business, which is expected to become its most significant vertical over time. The company anticipates double-digit growth in medical for the foreseeable future, having achieved this for the last three quarters.
- A major investment is the new Indianapolis facility, a 300,000 square-foot site (with expansion options) for medical contract manufacturing (CMO), which is nearing completion. This focus on CMO, including the ability to handle drugs, is expected to drive higher EBITDA margins and secure larger programs.
- The company boasts a strong balance sheet with reduced inventory and debt, providing capital for organic and inorganic growth. Kimball is actively pursuing M&A opportunities in the medical CMO space, particularly in the US and Europe.
- Kimball Electronics maintains a long-term relationship with a major medical customer (Phillips), supporting 11 business units across all regions. The company is positioned for continued growth in this relationship, including absorbing business from a closed facility and seeing solid ex-US growth.
Nov 18, 2025, 3:40 PM
Kimball Electronics (KE) Outlines Strategic Focus on Medical CMO Growth and Differentiated Capabilities
KE
New Projects/Investments
Revenue Acceleration/Inflection
M&A
- Kimball Electronics (KE) is strategically shifting its focus to aggressively grow its medical contract manufacturing (CMO) business, which is expected to become its largest and most profitable vertical over time. This includes significant investments in new facilities, such as the 300,000 sq ft Indianapolis plant, and pursuing inorganic growth opportunities.
- The company differentiates itself in medical CMO with FDA qualification and the ability to handle drug delivery, enabling it to manufacture devices, insert drugs, and ship them directly. This capability targets high-value programs like auto injectors for GLP-1s, on-body devices, and insulin delivery.
- Kimball Electronics reported approximately $1.5 billion in revenue for fiscal 2025 and has achieved double-digit growth in its medical segment for the last three quarters. The medical CMO space is anticipated to offer higher EBITDA margins and be accretive to overall company margins, with cash flow from other segments redeployed to fund this growth.
- KE maintains a long-term relationship with a major medical customer (Philips), serving 11 business units globally. Despite a $100 million annual revenue impact from a past FDA issue, Kimball has taken on all business from Philips' closed Pittsburgh facility and anticipates continued growth, particularly in ex-US markets.
Nov 18, 2025, 3:40 PM
Kimball Electronics Outlines Strategic Shift to Medical Business and Growth Plans
KE
New Projects/Investments
Revenue Acceleration/Inflection
M&A
- Kimball Electronics, a global electronic manufacturing services provider, projects $1.5 billion in revenue for fiscal 2025.
- The company is strategically focusing on its medical business, which has seen double-digit growth in the last three quarters and is expected to continue strong growth.
- Significant investment is being made in the medical contract manufacturing organization (CMO) space, including a new 300,000 sq ft facility in Indianapolis, with expectations for higher EBITDA margins from this segment.
- Kimball is actively pursuing organic and inorganic growth in medical CMO, targeting areas like drug delivery (e.g., auto injectors for GLP-1s) and surgical devices, and views outsourcing in medtech as a "mega trend".
- The company aims to aggressively grow its medical and industrial verticals, while its automotive business is expected to remain relatively flat, with the goal of medical becoming its most significant vertical over time.
Nov 18, 2025, 3:40 PM
Kimball Electronics Reports Q1 2026 Results, Reaffirms FY2026 Guidance
KE
Earnings
Guidance Update
Demand Weakening
- Kimball Electronics reported Q1 fiscal 2026 net sales of $365.6 million, a 2% decrease year-over-year, with adjusted net income of $12.3 million and adjusted diluted EPS of $0.49, up 2X from the prior year.
- The company achieved a gross margin rate of 7.9%, a 160 basis point increase compared to Q1 fiscal 2025, driven by favorable product mix, the closure of its Tampa facility, and global restructuring efforts.
- The medical segment saw strong growth with sales up 13% to $102 million, while automotive sales declined 10% to $164 million and industrial sales decreased 1% to $100 million.
- Kimball Electronics reiterated its fiscal 2026 guidance, expecting net sales between $1.35 billion and $1.45 billion and adjusted operating income of 4%-4.25% of net sales.
- The company generated $8.1 million in cash from operations, marking its seventh consecutive quarter of positive cash flow, and reduced borrowings by $9.5 million from the previous quarter to $138 million. It also invested $1.5 million in share repurchases.
Nov 6, 2025, 3:00 PM
Kimball Electronics Reports Q1 2026 Results and Reaffirms Fiscal 2026 Guidance
KE
Earnings
Guidance Update
Share Buyback
- Kimball Electronics reported net sales of $365.6 million, net income of $10.1 million, and diluted EPS of $0.40 for the first quarter ended September 30, 2025.
- The company reiterated its fiscal year 2026 guidance, projecting net sales between $1,350 million and $1,450 million and adjusted operating income of 4.0% to 4.25% of net sales.
- Operational highlights include $8.1 million in cash from operations for the seventh consecutive quarter and a reduction in debt to $138.0 million as of September 30, 2025.
- Sales in the medical vertical market increased by 13% year-over-year, while automotive sales decreased by 10% and industrial (excluding AT&M) decreased by 1%.
- During the quarter, the company repurchased 49,000 shares of common stock for $1.5 million.
Nov 5, 2025, 9:45 PM
Kimball Electronics Reports Strong Q1 Fiscal 2026 Results and Reiterates Full-Year Guidance
KE
Earnings
Guidance Update
Share Buyback
- Kimball Electronics reported Q1 Fiscal 2026 revenue of $365.6 million and net income of $10.1 million, with adjusted diluted EPS of $0.49, which is more than double the adjusted EPS from Q1 Fiscal 2025.
- The company's operating income for Q1 Fiscal 2026 was $14.5 million (4.0% of net sales), and adjusted operating income reached 4.8%, representing a 140 basis point improvement year-over-year.
- Kimball Electronics generated $8.1 million in cash from operations for the seventh consecutive quarter, reduced its debt by $9.5 million to $138.0 million, and achieved its lowest Cash Conversion Days in three years at 83.
- The company reiterated its Fiscal Year 2026 guidance, projecting net sales in the range of $1,350 million to $1,450 million and adjusted operating income between 4.0% and 4.25% of net sales.
Nov 5, 2025, 9:05 PM
Quarterly earnings call transcripts for Kimball Electronics.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more